|
|
|
|
LEADER |
02925nam a2200565 4500 |
001 |
ocn166252990 |
003 |
OCoLC |
005 |
20180501121913.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
070822s2002 caua ob 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d YDXCP
|d OCLCQ
|d UBY
|d IDEBK
|d E7B
|d OCLCQ
|d COF
|d OCLCQ
|d OPELS
|d OCLCQ
|d OPELS
|d OCLCF
|d KUK
|d OCLCQ
|d EBLCP
|d OCLCQ
|d OCLCO
|d OCLCA
|d GrThAP
|
019 |
|
|
|a 170957970
|a 505088978
|a 648270341
|a 808616294
|
020 |
|
|
|a 9780080496931
|q (electronic bk.)
|
020 |
|
|
|a 0080496938
|q (electronic bk.)
|
020 |
|
|
|a 012182246X
|q (electronic bk.)
|
020 |
|
|
|a 9780121822460
|q (electronic bk.)
|
035 |
|
|
|a (OCoLC)166252990
|z (OCoLC)170957970
|z (OCoLC)505088978
|z (OCoLC)648270341
|z (OCoLC)808616294
|
050 |
|
4 |
|a QP601
|b .M4eb pt. C
|
060 |
|
4 |
|a W1
|b ME9615K v.345 2002
|
060 |
|
4 |
|a QU 55
|b G1057 2002
|
072 |
|
7 |
|a SCI
|x 007000
|2 bisacsh
|
082 |
0 |
4 |
|a 572.6
|2 22
|
049 |
|
|
|a TEFA
|
245 |
0 |
0 |
|a G protein pathways.
|n Part C,
|p Effector mechanisms /
|c edited by Ravi Iyengar, John D. Hildebrandt.
|
246 |
3 |
0 |
|a Effector mechanisms
|
260 |
|
|
|a San Diego :
|b Academic Press,
|c ©2002.
|
300 |
|
|
|a 1 online resource (1 volume) :
|b illustrations (some color).
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Methods in enzymology ;
|v v. 345
|
504 |
|
|
|a Includes bibliographical references and indexes.
|
588 |
0 |
|
|a Print version record.
|
520 |
|
|
|a This third volume in the trio covering G proteins, features integrated approaches to studying G proteins. Methods pertaining to signaling mechanisms are presented, including theoretical and modeling approaches, biochemistry and molecular biology, and cell biology and physiology. The techniques for studying the structure and function of G proteins are important not only to those with specific research interests in them, but also endocrinologists and pharmacologists conducting research on signaling mechanisms that are increasingly understood to interact with G proteins.
|
650 |
|
0 |
|a G proteins.
|
650 |
1 |
2 |
|a GTP-Binding Proteins
|x physiology.
|0 (DNLM)D019204Q000502
|
650 |
2 |
2 |
|a Enzymes.
|0 (DNLM)D004798
|
650 |
2 |
2 |
|a Heterotrimeric GTP-Binding Proteins.
|0 (DNLM)D020962
|
650 |
2 |
2 |
|a Ion Channels.
|0 (DNLM)D007473
|
650 |
2 |
2 |
|a Signal Transduction.
|0 (DNLM)D015398
|
650 |
|
6 |
|a Protéines G.
|
650 |
|
7 |
|a SCIENCE
|x Life Sciences
|x Biochemistry.
|2 bisacsh
|
650 |
|
7 |
|a G proteins.
|2 fast
|0 (OCoLC)fst00936830
|
655 |
|
4 |
|a Electronic books.
|
700 |
1 |
|
|a Iyengar, Ravi.
|
700 |
1 |
|
|a Hildebrandt, John D.
|
776 |
0 |
8 |
|i Print version:
|t G protein pathways. Part C, Effector mechanisms.
|d San Diego : Academic Press, ©2002
|z 012182246X
|z 9780121822460
|w (OCoLC)48116848
|
830 |
|
0 |
|a Methods in enzymology ;
|v v. 345.
|
856 |
4 |
0 |
|u https://www.sciencedirect.com/science/bookseries/00766879/345
|z Full Text via HEAL-Link
|